background image
RESEARCH DIRECTORY
Dr. Karlsgodt's research
investigates the neural
circuitry underlying the
executive functions, such
as working memory, in
individuals with severe
psychiatric illness. Her work
has incorporated methods
such as functional magnetic
resonance imaging (fMRI),
diffusion tensor imaging
(DTI) and studies in relevant
patient populations such as
schizophrenia and bipolar
disorder.
Dr. Huerta is interested in
exploring the interactions
between the nervous system
and the immune system
in health and disease. He
currently studies brain
abnormalities occurring in
lupus and sepsis-induced
long-term cognitive deficit,
with the goal to isolate
key immune and neural
mechanisms with the purpose
of creating therapies for
autoimmunity and brain
disorders.
Dr. Kavoussi is dedicated to
the treatment of urological
disease through innovative
surgical procedures,
diagnostics and medical care.
The focus of Dr. Huston's
research is to understand how
the central nervous system
maintains homeostasis and
protects against traumatic
injury. He is currently studying
the beneficial effects of vagus
nerve stimulation with the
hope that it can improve care
of traumatized patients.
Dr. Gregersen conducts
international collaboration
efforts to achieve a
comprehensive genetic
description for autoimmune
diseases, with a particular
focus on lupus and
rheumatoid arthritis. He
also studies a number of
newly defined risk genes for
autoimmunity, several of
which are potential targets of
new drugs.
Dr. Kafantaris' main research
focus is the pharmacological
treatment of bipolar
disorder and the related
area of severe dysregulated
aggression associated
with conduct disorder or
oppositional defiant disorder.
She currently studies the
neurodevelopmental
underpinnings of bipolar
disorder and treatment with
lithium.
Dr. Guo studies antigen-
initiated B cell activation
under the influence of T cells.
He works to find a dialogue
between B cells and T cells
in immunity.
Dr. Kane's focus is in the field
of schizophrenia research.
His work has focused
on improving the early
diagnosis and treatment of
schizophrenia, as well as
developing new treatments
and treatment strategies to
enhance patient long-term
effectiveness and quality of
life.
KATHERINE KARLSGODT, PHD
Psychiatric Neuroscience
PATRICIO HUERTA, PHD
Autoimmune &
Musculoskeletal Disease
LOUIS R. KAVOUSSI, MD
Patient-Oriented Research
JARED HUSTON, MD
Biomedical Science
PETER K. GREGERSEN, MD
Genomics & Human Genetics
VIVIAN KAFANTARIS, MD
Psychiatric Neuroscience
BENCHANG GUO, PHD
Oncology & Cell Biology
JOHN M. KANE, MD
Psychiatric Neuroscience
26
2015 ANNUAL REPORT